Costa A - Search Results

1

Effect of tamoxifen on endometrial proliferation.

Decensi A, Fontana V, Bruno S, Gustavino C, Gatteschi B, Costa A. Decensi A, et al. Among authors: costa a. J Clin Oncol. 1996 Feb;14(2):434-40. doi: 10.1200/JCO.1996.14.2.434. J Clin Oncol. 1996. PMID: 8636754

2

Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy women.

Decensi A, Gandini S, Guerrieri-Gonzaga A, Johansson H, Manetti L, Bonanni B, Sandri MT, Barreca A, Costa A, Robertson C, Lien EA. Decensi A, et al. Among authors: costa a. J Clin Oncol. 1999 Sep;17(9):2633-8. doi: 10.1200/JCO.1999.17.9.2633. J Clin Oncol. 1999. PMID: 10561336 Clinical Trial.

3

Factors affecting plasma retinol decline during long-term administration of the synthetic retinoid fenretinide in breast cancer patients.

Torrisi R, Parodi S, Fontana V, Rondanina G, Formelli F, Costa A, Boccardo F, Decensi A. Torrisi R, et al. Among authors: costa a. Cancer Epidemiol Biomarkers Prev. 1994 Sep;3(6):507-10. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8000302

4

Breast cancer chemoprevention: studies with 4-HPR alone and in combination with tamoxifen using circulating growth factors as potential surrogate endpoints.

Decensi A, Formelli F, Torrisi R, Costa A. Decensi A, et al. Among authors: costa a. J Cell Biochem Suppl. 1993;17G:226-33. doi: 10.1002/jcb.240531142. J Cell Biochem Suppl. 1993. PMID: 8007703 Clinical Trial.

5

Effect of the synthetic retinoid fenretinide on dark adaptation and the ocular surface.

Decensi A, Torrisi R, Polizzi A, Gesi R, Brezzo V, Rolando M, Rondanina G, Orengo MA, Formelli F, Costa A. Decensi A, et al. Among authors: costa a. J Natl Cancer Inst. 1994 Jan 19;86(2):105-10. doi: 10.1093/jnci/86.2.105. J Natl Cancer Inst. 1994. PMID: 8271292 Clinical Trial.

6

Retinoids and tamoxifen in breast cancer chemoprevention.

Costa A, Sacchini V, Decensi A. Costa A, et al. Int J Clin Lab Res. 1993;23(2):53-5. doi: 10.1007/BF02592283. Int J Clin Lab Res. 1993. PMID: 8518414

7

Long-term effects of fenretinide on retinal function.

Decensi A, Fontana V, Fioretto M, Rondanina G, Torrisi R, Orengo MA, Costa A. Decensi A, et al. Among authors: costa a. Eur J Cancer. 1997 Jan;33(1):80-4. doi: 10.1016/s0959-8049(96)00351-6. Eur J Cancer. 1997. PMID: 9071904 Clinical Trial.

8

Effect of fenretinide on plasma IGF-I and IGFBP-3 in early breast cancer patients.

Torrisi R, Parodi S, Fontana V, Pensa F, Casella C, Barreca A, De Palo G, Costa A, Decensi A. Torrisi R, et al. Among authors: costa a. Int J Cancer. 1998 Jun 10;76(6):787-90. doi: 10.1002/(sici)1097-0215(19980610)76:6<787::aid-ijc3>3.0.co;2-u. Int J Cancer. 1998. PMID: 9626341

9

Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.

Favoni RE, de Cupis A, Bruno S, Yee D, Ferrera A, Pirani P, Costa A, Decensi A. Favoni RE, et al. Among authors: costa a. Br J Cancer. 1998 Jun;77(12):2138-47. doi: 10.1038/bjc.1998.358. Br J Cancer. 1998. PMID: 9649125 Free PMC article.

10

Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group.

Decensi A, Robertson C, Rotmensz N, Severi G, Maisonneuve P, Sacchini V, Boyle P, Costa A, Veronesi U. Decensi A, et al. Among authors: costa a. Br J Cancer. 1998 Sep;78(5):572-8. doi: 10.1038/bjc.1998.542. Br J Cancer. 1998. PMID: 9744493 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,810 results

Search Page

Filters